Inhalation Products

In inhalation drug development, SkyePharma offers:

Cost effective devices

Proprietary formulation technologies

SkyePharma uses a range of novel excipients in its formulation technologies to optimise dose-to-dose repeatability; a major hurdle for regulatory approval of inhalation products.

Copyright 2008, SkyePharma. All Rights Reserved.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom

For enquiries, please
contact us.